what does biocon foundation do

The Biocon Foundation, established by Biocon Limited, focuses on initiatives related to health, education, and rural development, particularly in India, aiming to improve community welfare and support sustainable practices through various programs and partnerships.

what does biocon limited do

Biocon Limited engages in the manufacturing of biotechnology products and offers research services, operating as a global biopharmaceutical company dedicated to affordable innovation and developing lifesaving therapies for patients worldwide.

what does biocon company do

Biocon Company, founded in 1978 by Kiran Mazumdar-Shaw, is involved in the creation and production of biopharmaceuticals and biologics, with a mission to enhance healthcare access through affordable solutions and global operations.

what does biocon biologics do

Biocon Biologics refers to the company's specialized segment focused on developing and manufacturing complex therapeutic proteins and biologics, which are used to treat various diseases and are part of their broader portfolio of biopharmaceutical products.

what does biocon dios mean

BIOS at Biocon Limited stands for Biologics Operations Infrastructure Strategy, which is an initiative aimed at optimizing the company's manufacturing capabilities and supply chain to efficiently produce and deliver biopharmaceutical products globally.

BIOCON

BSE

F&O

Biocon Limited

Healthcare· Pharmaceuticals & Biotechnology· INE376G01013· Scrip: 532523

EN हिन्दी ગુજરાતી मराठी

₹४१४.०५

▲ 2.20 (+0.00%)

2026-06-10

BSE

₹४१४.०५

▲ २.२०

+०.००%

२२८ कारोबारी दिन · 1Y अवधि

आज (BSE)

खुलना४१६.७५

उच्च४२१.२०

निम्न४१२.९०

पिछला बंद४१६.२५

मात्रा५१,१६८

मूल्य₹२.१Cr

L: 412.90H: 421.20

जानकारी

अंकित मूल्य₹५

सूचीबद्ध2004-04-07

ISININE376G01013

SeriesA

BSE स्क्रिप532523

मुख्य संकेतक

1D

—

1W

—

1M

—

3M

—

6M

—

मूल्यांकन

P/E (TTM)—

P/E (Qtr Ann.)—

P/Sales—

बाज़ार पूंजी—

वृद्धि (तिमाही)

राजस्व+6.43%

PAT+199.26%

EPS+261.54%

लाभप्रदता

EBITDA मार्जिन२३.०%

शुद्ध मार्जिन२.१%

TTM EBITDA M.२३.५%

TTM शुद्ध M.२.८%

लाभांश

यील्ड—

नवीनतम DPS₹०.५

भुगतान अनुपात२३८.१%

वृद्धि+0.00%

TTM राजस्व

₹11840 Cr

TTM EBITDA

₹2778 Cr

TTM PAT

₹332 Cr

TTM EPS

₹१.२२

प्रति शेयर राजस्व

₹७३.०

त्रैमासिक वित्तीय

राजस्व

EBITDA

PAT

EPS

तिमाही	राजस्व	Expenses	EBITDA	PBT	PAT	EPS
2024-12-31	3821 Cr	3718 Cr	880 Cr	156 Cr	81 Cr	₹0.21
2024-09-30	3590 Cr	3551 Cr	815 Cr	98 Cr	27 Cr	₹-0.13
2024-06-30	511 Cr	551 Cr	32 Cr	1 Cr	1 Cr	₹0.01
2024-03-31	3917 Cr	3635 Cr	1052 Cr	322 Cr	223 Cr	₹1.13
2023-12-31	3954 Cr	3708 Cr	1568 Cr	832 Cr	753 Cr	₹5.52
2023-09-30	3462 Cr	3358 Cr	917 Cr	239 Cr	173 Cr	₹1.05
2023-03-31	3774 Cr	3389 Cr	1231 Cr	537 Cr	415 Cr	₹2.62
2022-12-31	2941 Cr	2718 Cr	447 Cr	30 Cr	-21 Cr	₹-0.35

शेयरधारिता पैटर्न

वर्तमान — 2026-03-31

प्रमोटर44.9%

FII7.5%

DII24.1%

सार्वजनिक55.0%

प्रमोटर होल्डिंग ट्रेंड

कॉर्पोरेट कार्यवाही

एक्स-तारीख	प्रकार	उद्देश्य
2026-07-03	Dividend	Dividend - Re 0.50 Per Share
2025-07-04	Dividend	Dividend - Rs 0.50 Per Share
2024-07-05	Dividend	Dividend - Re 0.50 Per Share
2023-07-07	Dividend	Dividend - Rs 1.50 Per Share
2022-06-30	Dividend	Dividend - Rs 0.50 Per Share
2019-07-18	Dividend	Dividend - Rs 0.50 Per Share
2019-06-12	Bonus	Bonus 1:1
2018-07-19	Dividend	Dividend- Re 1 Per Share
2017-07-20	Dividend	Annual General Meeting/Dividend - Re 1/- Per Share
2017-06-15	Bonus	Bonus 2:1
2016-06-22	Other	Annual General Meeting
2016-03-17	Dividend	Interim Dividend - Rs 5/- Per Share (Purpose Revised)
2015-07-16	Other	Annual General Meeting
2015-04-09	Dividend	Interim Dividend Rs 5/- Per Share
2014-07-10	Dividend	Annual General Meeting / Final Dividend - Rs 5/- Per Share
2013-07-11	Dividend	Annual General Meeting/Final Dividend Rs 5/- Per Share + Special Dividend Rs 2.5/- Per Share
2012-07-05	Dividend	Annual General Meeting / Dividend Rs 5 Per Share
2011-07-07	Dividend	Annual General Meeting/Dividend Rs 3 Per Share
2011-05-05	Dividend	Interim Dividend-Rs.1.50 Per Share (Purpose Revised)
2010-07-08	Dividend	Annual General Meeting And Dividend Rs.3.50 Per Share

आय विवरण

Biocon Limited has informed the Exchange about Investor Presentation

1 Jun 2026NSE30K chars

Read →

Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

8 May 2026BSE1K chars

Read →

Biocon Limited has informed the Exchange about Investor Presentation

8 May 2026NSE10K chars

Read →

Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

7 Apr 2026BSE2K chars

Read →

Biocon Limited has informed the Exchange about Investor Presentation

9 Dec 2025NSE31K chars

Read →

Biocon Limited has informed the Exchange about Investor Presentation

12 Nov 2025NSE10K chars

Read →

मूल्य इतिहास

तारीख	खुलना	उच्च	निम्न	बंद	मात्रा
2026-06-10	४१६.५५	४२१.५५	४१२.८०	४१४.६०	३०.०१L
2026-06-03	४१५.००	४१७.३५	४११.१५	४१२.४५	२३.६८L
2026-05-27	४३६.१५	४३८.४५	४३०.३०	४३२.२०	२५.७३L
2026-05-26	४३०.०५	४४०.४०	४२९.५०	४३६.१५	७१.०७L
2026-05-25	४३०.५५	४३२.५०	४२७.१५	४३०.०५	१९.७७L
2026-05-22	४३३.००	४३३.२०	४२१.७५	४३०.२५	३७.७८L
2026-05-21	४३६.००	४३६.७५	४२९.१०	४३०.८५	२६.८४L
2026-05-20	४२६.००	४३६.९०	४२५.२०	४३२.७०	४८.४५L
2026-05-19	४२७.००	४३५.७५	४२५.१५	४२८.१५	३९.८४L
2026-05-18	४२८.४५	४३१.८५	४२२.३५	४२६.२५	३३.९४L
2026-05-15	४१८.००	४३४.६०	४१७.३०	४३०.१०	८१.७७L
2026-05-14	४१७.५५	४२४.४०	४१६.५०	४१९.००	८०.९०L
2026-05-13	४०३.०५	४२०.२५	४०२.८५	४१७.६०	१.१४Cr
2026-05-12	३९२.९०	४०६.६०	३९२.२५	४०२.४५	१.१२Cr
2026-05-11	३८०.४५	३९६.२५	३७१.७५	३९०.४५	१.२९Cr
2026-05-08	३७९.००	३९६.४०	३७७.२५	३८०.४०	५६.८०L
2026-05-07	३८४.००	३८६.३०	३७९.६०	३८२.२५	५२.२९L
2026-05-06	३७२.८०	३८४.५०	३७१.०५	३८०.६०	६२.३१L
2026-05-05	३६०.६०	३७०.९०	३५९.२०	३६८.२५	२६.६१L
2026-05-04	३५९.२०	३६६.५०	३५९.२०	३६०.६०	२६.०८L
2026-04-30	३६०.५०	३६१.६५	३५४.२५	३५९.६५	१९.९७L
2026-04-29	३६४.७०	३६८.२०	३६१.२५	३६२.२५	१४.७७L
2026-04-28	३६१.९५	३६४.७०	३५९.१५	३६२.८०	४१.९८L
2026-04-27	३५१.२५	३६२.५५	३५०.५०	३६२.००	४०.५८L
2026-04-24	३५८.०५	३५८.९५	३४८.५०	३४९.८५	१५.८६L
2026-04-23	३५७.४५	३६४.८०	३५५.६०	३५८.००	२२.९९L
2026-04-22	३६२.४५	३६२.५०	३५६.२०	३५७.८०	२६.०१L
2026-04-21	३६०.००	३६४.७०	३५९.०५	३६१.५०	२२.३७L
2026-04-20	३५९.५०	३६२.५०	३५५.०५	३५९.०५	१८.६८L
2026-04-17	३५१.००	३५८.७०	३४९.१५	३५८.१०	२४.२३L

अक्सर पूछे जाने वाले प्रश्न

के बारे में

बायोकॉन लिमिटेड, 1978 में स्थापित एक भारतीय बायोफार्मास्युटिकल कंपनी, जेनेरिक सक्रिय फार्मास्युटिकल सामग्री (एपीआई) के निर्माण और किफायती बायोलॉजिक्स विकसित करने में माहिर है। यह बेंगलुरु और अमेरिका में मुख्यालय के साथ विश्व स्तर पर संचालित होता है, और नवाचार के माध्यम से सुलभ स्वास्थ्य देखभाल पर ध्यान केंद्रित करने के लिए जाना जाता है।

BOARD OF DIRECTORS

Meleveetil Damodaran

Independent Director

DEPARTED

Nicholas Robert Haggar

Independent Director

Vijay Kumar Kuchroo

Independent Director

DEPARTED

DEPARTED

Ravi Rasendra Mazumdar

Siddharth Mittal